In a solo episode, clinician-educator Nico Misleh lays out a pragmatic, experience-driven approach to lab testing in hormone replacement therapy (HRT). He challenges two extremes, “no labs” and “too many labs”, and argues for a balanced strategy that uses targeted serum testing to improve outcomes, reduce guesswork, and avoid unnecessary costs. Below is a concise guide to the key lessons, clinical examples, and practical takeaways Nico shared for providers who want better results with HRT and TRT patients.
Why Labs Matter (But Not All Labs Are Equal)
Nico frames the debate in two camps. On one end, some conventional voices treat labs as optional, relying heavily on symptoms alone. On the other end, many functional medicine practices order dozens of assays (dried urine, salivary panels, long lists of biomarkers) that can be costly, confusing, and sometimes low-yield. Nico recommends a middle path:
- Use serum testing as the current clinical gold standard for hormones.
- Order focused labs that change management and patient outcomes.
- Avoid routine reliance on complicated dried urine or salivary hormone assays unless specific evidence supports them for the clinical question at hand.
Five Lab Insights That Can Help Your Patients
Nico highlights five practical lab insights that routinely save patients from misdiagnosis or suboptimal treatment:
- 1. Serum testing over exotic assays. Randomized controlled trials and most clinical evidence rely on serum measures. Serum provides reliable targets for treatment and is less prone to patient errors than dried urine or saliva.
- 2. Free testosterone matters more than total testosterone. Total testosterone can be misleading. Free testosterone correlates better with symptoms. If a patient reports low energy and low libido, check free T, not only total T.
- 3. Check SHBG (sex hormone–binding globulin). High SHBG can “hide” low free testosterone by binding circulating hormone. A patient with a high total T but high SHBG may still have functional low-androgen symptoms.
- 4. Target evidence-based hormone ranges. Some serum targets are linked to clinical outcomes, such as estradiol levels associated with bone and cardiovascular benefit, or progesterone thresholds for endometrial protection. Use those targets as guides, not dogma.
- 5. Don’t forget non-hormone labs. Ferritin and iron status are critical, especially in younger women. Low ferritin can drive fatigue, cognitive slowing, and even severe neuropsychiatric symptoms that mimic or worsen hormonal syndromes.
Clinical Examples
Nico shares three concrete cases that show why targeted labs are indispensable.
Greg: High total Testosterone with high SHBG: the free Testosterone problem:
A 65-year-old male named “Greg” complained of fatigue, low drive, and poor exercise recovery. His primary care lab showed very high total testosterone, seemingly normal or excellent. But when Nico ordered an SHBG and calculated free testosterone, the picture changed: SHBG was very high (around 90s) and free testosterone was very low. The explanation: a tank full of gas (total T) but no gas in the engine (free T). Without checking SHBG and free T, Greg might have been misdiagnosed or given small, ineffective doses of testosterone. Knowing SHBG changed the plan: higher, better-timed dosing to overcome the binding “saturation” and restore meaningful free hormone levels.
Betty: Menopause and objective targets
For an older woman clearly in menopause, labs might not be required to recognize symptoms, but they add enormous value. Measurements like serum estradiol (with evidence suggesting thresholds associated with bone/CV protection) and progesterone (for endometrial and CNS protection) provide concrete targets. Showing patients before-and-after labs helps them trust treatment and understand the mechanism of benefit.
Young woman with psychosis-like symptoms: ferritin saved the case
A 21‑year-old with new-onset severe anxiety and intermittent psychosis did not respond fully to progesterone replacement alone. Routine labs revealed a ferritin of about 20. Low enough to cause neuropsychiatric symptoms. After targeted iron supplementation with a bioavailable form (e.g., iron glycinate), her psychotic symptoms resolved within days to a week. This case underscores how non-hormonal labs (iron, thyroid) can be the missing piece in complex HRT cases.
How To Use Labs Effectively: Practical Tips
- Order a focused initial panel: serum estradiol, progesterone (where applicable), total and free testosterone, SHBG, ferritin, TSH/free T4, and basic metabolic markers.
- Interpret labs with evidence-based “optimal” ranges in mind, not just broad reference intervals.
- Use lab changes as a guide for dosing, frequency, and adjunctive support (e.g., iron for low ferritin).
- Communicate results to patients in plain language. Analogies work (tank vs. engine, Pac-Man binding proteins) and build trust.
Conclusion: Labs Are The Guide, Not The Gospel
Nico’s message is simple and actionable: labs are a tool to marry objective data with patient symptoms. They stop guessing, expose hidden mechanisms (SHBG, iron deficiency), and improve outcomes. They should be selected thoughtfully, neither abandoned nor overused. Providers who learn to order the right serum tests and interpret them well will help patients faster, avoid unnecessary treatments, and build a stronger practice.
FAQ
Q: Which labs should I order at an initial HRT consult?
A: Start with serum total and free testosterone, SHBG, estradiol (if female), progesterone when relevant, ferritin, TSH/free T4, and a basic metabolic panel. Tailor further testing to clinical clues.
Q: Is free testosterone really better than total testosterone?
A: Yes! Free T correlates much better with symptoms because it represents a biologically available hormone. Total T can be misleading when SHBG is abnormal.
Q: When should I check ferritin?
A: In all menstruating women and in anyone with fatigue, cognitive slowing, restless legs, or heavy menses. Ferritin under ~35 ng/mL should raise concern; values under ~20 often cause clinical symptoms.
Q: How often should labs be rechecked after starting HRT?
A: Reassess clinically and check labs after dose changes or at 6–12 weeks for many hormones; longer intervals may be appropriate once stable. Use symptoms and lab trends together to guide timing.
Get More Practical Tips About Lab Work & How To Serve Your Patients
Want daily, practical HRT education and clinical pearls from Nico? Join Nico’s FREE Daily Newsletter!
*Yes, it’s every day, and yes, clinicians stay subscribed. It’s a fast way to get case-based tips, lab insights, and business sense for your practice!*
